1 Gillies, G. E., Pienaar, I. S., Vohra, S. & Qamhawi, Z. Sex differences in Parkinson’s disease. Frontiers in neuroendocrinology 35, 370-384 (2014).
2 Miller, I. N. & Cronin‐Golomb, A. Gender differences in Parkinson's disease: clinical characteristics and cognition. Movement disorders 25, 2695-2703 (2010).
3 Chaudhuri, K. R., Healy, D. G. & Schapira, A. H. Non-motor symptoms of Parkinson's disease: diagnosis and management. The Lancet Neurology 5, 235-245 (2006).
4 Aarsland, D. et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75, 1062-1069 (2010).
5 Arie, L., Herman, T., Shema-Shiratzky, S., Giladi, N. & Hausdorff, J. Do cognition and other non-motor symptoms decline similarly among patients with Parkinson’s disease motor subtypes? Findings from a 5-year prospective study. Journal of neurology 264, 2149-2157 (2017).
6 Muslimović, D. Cognitive sequelae of Parkinson’s disease: nature, course, risk factors and functional impact. (2009).
7 Muslimović, D., Post, B., Speelman, J. D. & Schmand, B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65, 1239-1245 (2005).
8 Yu, R.-L. et al. Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan. Parkinsonism & related disorders 18, 1067-1072 (2012).
9 McCarrey, A. C., An, Y., Kitner-Triolo, M. H., Ferrucci, L. & Resnick, S. M. Sex differences in cognitive trajectories in clinically normal older adults. Psychology and aging 31, 166 (2016).
10 Munro, C. A. et al. Sex differences in cognition in healthy elderly individuals. Aging, Neuropsychology, and Cognition 19, 759-768 (2012).
11 Gao, L. et al. Sex differences in cognition among Chinese people with Parkinson’s disease. Journal of Clinical Neuroscience 22, 488-492 (2015).
12 Bayram, E., Banks, S. J., Shan, G., Kaplan, N. & Caldwell, J. Z. Sex Differences in Cognitive Changes in De Novo Parkinson’s Disease. Journal of the International Neuropsychological Society, 1-9 (2019).
13 Reekes, T. H. et al. Sex specific cognitive differences in Parkinson disease. npj Parkinson's Disease 6, 1-6 (2020).
14 Lubomski, M., Rushworth, R. L., Lee, W., Bertram, K. L. & Williams, D. R. Sex differences in Parkinson’s disease. Journal of Clinical Neuroscience 21, 1503-1506 (2014).
15 Augustine, E. F. et al. Sex differences in clinical features of early, treated Parkinson’s disease. PloS one 10, e0133002 (2015).
16 Lin, S.-J., Baumeister, T. R., Garg, S. & McKeown, M. J. Cognitive profiles and hub vulnerability in Parkinson's disease. Frontiers in neurology 9, 482 (2018).
17 Szewczyk-Krolikowski, K. et al. The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism & related disorders 20, 99-105 (2014).
18 Hughes, T. et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease. Neurology 54, 1596-1603 (2000).
19 Cholerton, B. et al. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. Parkinsonism & related disorders 50, 29-36 (2018).
20 Song, Y., Gu, Z., An, J., Chan, P. & Group, C. P. S. Gender differences on motor and non-motor symptoms of de novo patients with early Parkinson’s disease. Neurological Sciences 35, 1991-1996 (2014).
21 Liu, R. et al. Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease. Neurology 84, 2107-2115 (2015).
22 Locascio, J. J., Corkin, S. & Growdon, J. H. Relation between clinical characteristics of Parkinson's disease and cognitive decline. Journal of clinical and experimental neuropsychology 25, 94-109 (2003).
23 Riedel, O. et al. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 255, 255-264 (2008).
24 Freeman, G. & Halton, J. H. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 38, 141-149 (1951).
25 Goldman, J. G. et al. Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health. npj Parkinson's Disease 4, 1-11 (2018).
26 Watson, G. S. & Leverenz, J. B. Profile of cognitive impairment in Parkinson's disease. Brain Pathology 20, 640-645 (2010).
27 Hanna-Pladdy, B., Jones, K., Cabanban, R., Pahwa, R. & Lyons, K. E. Predictors of mild cognitive impairment in early-stage Parkinson's disease. Dementia and geriatric cognitive disorders extra 3, 168-178 (2013).
28 Bouquet, C. A., Bonnaud, V. & Gil, R. Investigation of supervisory attentional system functions in patients with Parkinson’s disease using the Hayling task. Journal of Clinical and Experimental Neuropsychology 25, 751-760 (2003).
29 Brown, R. & Marsden, C. Internal versus external cues and the control of attention in Parkinson's disease. Brain 111, 323-345 (1988).
30 De Frias, C. M., Nilsson, L. G. & Herlitz, A. Sex differences in cognition are stable over a 10-year period in adulthood and old age. Aging, Neuropsychology, and Cognition 13, 574-587 (2006).
31 Spencer, R. J. et al. Psychometric limitations of the mini-mental state examination among nondemented older adults: an evaluation of neurocognitive and magnetic resonance imaging correlates. Experimental aging research 39, 382-397 (2013).
32 Currie, L. J., Harrison, M. B., Trugman, J. M., Bennett, J. P. & Wooten, G. F. Postmenopausal estrogen use affects risk for Parkinson disease. Archives of neurology 61, 886-888 (2004).
33 Marder, K. et al. Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology 50, 1141-1143 (1998).
34 Haaxma, C. A. et al. Gender differences in Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry 78, 819-824 (2007).
35 Dluzen, D. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain research 767, 340-344 (1997).
36 Gajjar, T., Anderson, L. & Dluzen, D. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system. Journal of neural transmission 110, 1215-1224 (2003).
37 Jacobs, D. M. et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology 50, 368-373 (1998).
38 Yaffe, K., Sawaya, G., Lieberburg, I. & Grady, D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. Jama 279, 688-695 (1998).
39 Wooten, G., Currie, L., Bovbjerg, V., Lee, J. & Patrie, J. Are men at greater risk for Parkinson’s disease than women? Journal of Neurology, Neurosurgery & Psychiatry 75, 637-639 (2004).
40 Yang, K. et al. Cognitive characteristics in Chinese non-demented PD patients based on gender difference. Translational neurodegeneration 7, 16 (2018).